| 
Results for biologics. Search took 0.02 seconds.
Merck's Gardasil, Approved For New Uses
in Straightfromthedoc, on September 16, 2008
... cervical cancer ," said Jesse L. Goodman, M.D., M.P.H., director of the FDA's Center for Biologics Evaluation and Research. "While vulvar and vaginal cancers are rare, the opportunity ...
Rotavirus-Caused Gastroenteritis Vaccine Rotarix: Approved by US FDA
in Straightfromthedoc, on April 4, 2008
...fects so many children," said Jesse L. Goodman, M.D., M.P.H., director of FDA's Center for Biologics Evaluation and Research.
During studies involving more than 24,000 infants, Rotarix was e...
Fibrin Sealant, Artiss: FDA-Approved for Burn Patients
in Straightfromthedoc, on March 19, 2008
...placement on burn sites," said Jesse L. Goodman M.D., M.P.H., director of FDA's Center for Biologics Evaluation and Research. "The approval also provides an additional choice for health ...
National Awareness Campaign Surrounding Follow-On Biologics
in The Biotech Weblog, on February 11, 2008
... Richmond -based Insmed, Inc has just launched a broad follow-on biologics education campaign . Part of the innovative campaign is the launch of a YouTube video on Friday to encourage an on-li...
Nasal Influenza Vaccine Flumist®, Now FDA-Approved for Children Ages 2-5
in Straightfromthedoc, on September 20, 2007
...to include children aged 2-5.
According to Jesse L. Goodman, M.D., director, FDA's Center for Biologics Evaluation and Research:
"The goal of preventing influenza is now more attainable wi...
Schuppenflechte, Psoriasis: neue Patientenbroschuere
in Das Gesundheits-Weblog, on July 6, 2007
...enflechte - Die Erkrankung behandeln", "Schuppenflechte - Die Therapie mit Biologics" und jetzt neu "Schuppenflechte - Mit der Erkrankung leben". Die Broschüren sollen dazu be...
Again pharmaceutical: RFID can boost service level...
in Supplychainer, on November 15, 2006
...ddress significant challenges including global standards, privacy concerns and the safe handling of biologics," said Mr Jackson.
The importance of increasing security in the pharmaceutical is cr...
Merck Acquires GlycoFi and Abmaxis for $480 Million
in The Biotech Weblog, on May 10, 2006
...
Pharmaceutical company Merck is definitely expanding its biologics protfolio. The firm just acquired two biotech companies: GlycoFi, Inc. and Abmaxis, Inc .
lebanon -based GlycoFi bo...
FDA seeking participants for Nanotechnology Public Meeting
in Nanotechbuzz, on April 14, 2006
...y supplements), food and color additives, animal feeds, cosmetics, human and animal drugs and human biologics and medical devices;
About any specific scientific issues related to the development of t...
Cervical Cancer Vaccine Gets Priority Review From FDA
in The Biotech Weblog, on February 10, 2006
...rivalent human papillomavirus recombinant vaccine), will be given priority review by the US FDA. A Biologics License Application has been filed, and, with the expedited processing (standard is 10 mont...
Biotech and Pharmaceutical Outsourcing In China/Asia
in The Biotech Weblog, on January 5, 2006
...n China
Manufacturing, API's, and Generics
SFDA Insights on Clinical Trials, GMP, and Drugs/Biologics
Commercialization & Marketing Strategies in the Chinese Market
East/West Partnersh...